Human immunodeficiency virus and the liver: The impact of coinfection withhepatotropic viruses

被引:4
|
作者
Huerta, Leonor [1 ]
Anaya-Covarrubias, Julio Y. [2 ,3 ]
Fierro, Nora A. [1 ,2 ,3 ]
机构
[1] Univ Nacl Autonoma Mexico, Biomed Res Inst, Dept Inmunol, Ciudad De Mexico 045210, Mexico
[2] Civil Hosp Guadalajara Fray Antonio Alcalde, Dept Mol Biol Med, Guadalajara, Jalisco, Mexico
[3] Univ Guadalajara, Hlth Sci Ctr, Guadalajara, Jalisco, Mexico
关键词
Liver disease; Human immunodeficiency virus; Hepatitis B virus; Hepatitis C virus; Hepatitis E virus; Coinfection; INFECTION;
D O I
10.1016/j.aohep.2019.03.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Human immunodeficiency virus (HIV) predisposes for liver damage during coinfection with hepatitis E virus (HEV) and increases the replication of hepatitis C virus (HCV). HIV-hepatitis B virus (HBV) coinfections are common. In Mexico, hepatotropic viruses are major causative agents of liver disease. However, information on HIV coinfections is limited in the country. (C) 2019 Published by Elsevier Espana, S.L.U. on behalf of Fundacion Clinica Medica Sur, A.C.
引用
收藏
页码:285 / 286
页数:2
相关论文
共 50 条
  • [21] Human immunodeficiency virus and tuberculosis coinfection: clinical features and predictors of mortality
    Gumuser, Fatma
    Altinkaynak, Merve
    Yildiz Sevgi, Dilek
    Altuntas Aydin, Ozlem
    Mete, Bilgul
    Gunduz, Alper
    Kumbasar Karaosmanoglu, Hayat
    Bolukcu, Sibel
    Tabak, Omer Fehmi
    Vahaboglu, Mustafa Haluk
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (03) : 503 - 508
  • [22] Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection
    Hofmann, Eveline
    Surial, Bernard
    Boillat-Blanco, Noemie
    Guenthard, Huldrych F.
    Stoeckle, Marcel
    Bernasconi, Enos
    Schmid, Patrick
    Calmy, Alexandra
    Suter-Riniker, Franziska
    Rauch, Andri
    Wandeler, Gilles
    Beguelin, Charles
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (04) : 730 - 733
  • [23] Treponema and Bartonella Coinfection in a Human Immunodeficiency Virus-Positive Individual
    Ogawa, Lauren
    Alasady, Hussein
    Terriquez, Joel
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2021, 29 (04) : E244 - E245
  • [24] Human immunodeficiency virus infection and the liver
    Crane, Megan
    Iser, David
    Lewin, Sharon R.
    WORLD JOURNAL OF HEPATOLOGY, 2012, 4 (03) : 91 - 98
  • [25] Human immunodeficiency virus infection and the liver
    Megan Crane
    David Iser
    Sharon R Lewin
    World Journal of Hepatology, 2012, 4 (03) : 91 - 98
  • [26] Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
    Kanada, Aimi
    Takehara, Tetsuo
    Ohkawa, Kazuyoshi
    Kato, Michio
    Tatsumi, Tomohide
    Miyagi, Takuya
    Sakamori, Ryotaro
    Yamaguchi, Shinjiro
    Uemura, Akio
    Kohga, Keisuke
    Sasakawa, Akira
    Hikita, Hayato
    Kawamura, Kiyomi
    Kanto, Tatsuya
    Hiramatsu, Naoki
    Hayashi, Norio
    HEPATOLOGY RESEARCH, 2008, 38 (06) : 622 - 628
  • [27] Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones
    Sasadeusz, J
    INTERNAL MEDICINE JOURNAL, 2001, 31 (07) : 418 - 421
  • [28] Hepatitis E virus coinfection with hepatotropic viruses in Egyptian children
    Zaki, Maysaa El Sayed
    Salama, Osama Saad
    Mansour, Fathy Awaad
    Hossein, Shaimaa
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2008, 41 (03) : 254 - 258
  • [29] Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia
    Vinikoor, Michael J.
    Sinkala, Edford
    Chilengi, Roma
    Mulenga, Lloyd B.
    Chi, Benjamin H.
    Zyambo, Zude
    Hoffmann, Christopher J.
    Saag, Michael S.
    Davies, Mary-Ann
    Egger, Matthias
    Wandeler, Gilles
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (10) : 1343 - 1349
  • [30] Fatty Liver Disease in Human Immunodeficiency Virus-Hepatitis B Virus Coinfection: A Cause for Concern COMMENT
    Woreta, Tinsay A.
    Chalasani, Naga
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E3286 - E3287